Intraventricular quinupristin/dalfopristin for the treatment of vancomycin-resistant Enterococcus faecium shunt infection

Clin Infect Dis. 1998 Jun;26(6):1460-1. doi: 10.1086/517663.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / therapeutic use*
  • Drug Resistance, Microbial
  • Drug Therapy, Combination
  • Enterococcus faecium
  • Gram-Positive Bacterial Infections / drug therapy*
  • Humans
  • Injections, Intraventricular
  • Male
  • Vancomycin / therapeutic use*
  • Ventriculoperitoneal Shunt / adverse effects*
  • Virginiamycin / administration & dosage
  • Virginiamycin / analogs & derivatives*
  • Virginiamycin / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Virginiamycin
  • quinupristin
  • Vancomycin
  • dalfopristin